The EV Platform Built for the Real World.

Most exosome serums cannot tell you what is actually in them. BioThera can: 30 billion verified EVs per mL, MISEV2023-compliant characterization, and active clinical evaluation alongside dermatologist partners. This is what rigorous, accountable EV skincare actually looks like.

Extracellular Vesicle (EV/Exosome)

Real-time structural model showing the bioactive molecules found in this nanoscale delivery system

Phospholipid bilayerSurface proteinsBiomolecular coronaIntraluminal cargoRNA molecules

What Does BioThera Solutions Do?

BioThera Solutions operates across three integrated layers: plant-derived EV isolation and MISEV2023-compliant biomanufacturing, rigorous particle characterization, and commercial product formulation. The company’s first commercial application is the mPDEV Serum — a Health Canada-notified dermo-cosmetic containing plant-derived extracellular vesicles from Aloe barbadensis.

EV Biomanufacturing

Scalable. Standardized. Reproducible.

Our proprietary processes are engineered for consistency at scale — delivering batch-level characterization, cold-chain integrity, and MISEV-aligned quality control across plant-derived and future mammalian EV modalities.

Dermocosmetic Application

Clinically Evaluated. Science-First.

The mPDEV (Exosome) Serum is our initial application: plant-derived extracellular vesicles (EVs/exosomes) formulated for professional dermocosmetic use, with active clinical evaluation underway alongside dermatologist partners.

Platform Vision

Built for Every EV Modality.

Dermocosmetics is the entry point, not the ceiling. Our biomanufacturing infrastructure is designed to be modality-agnostic — supporting plant-derived EVs today, with the architecture to scale across human-derived, stem cell-derived, and next-generation EV sources for regenerative medicine, drug delivery, and therapeutic biologics.

mPDEV (Exosome) Serum

The mPDEV Serum is our flagship dermocosmetic formulation — a precision-manufactured EV/exosome serum built to the standards dermatologists actually demand. Every batch is NTA-verified, characterized to specification, and validated for cosmetic compliance before release.

  • Guaranteed 30 billion particles/mL — 6.75 mL tube
  • Derived from a medicinal plant with antioxidant, anti-inflammatory, and wound-healing properties — 100% plant-sourced
  • Health Canada cosmetic notification: complete
  • FDA cosmetic-aligned
  • Leaping Bunny certified — no animal testing at any production stage
  • Active clinical evaluation with dermatologist partners
mPDEV (Exosome) Serum
Deployed in Clinics
Health Canada Notified
Leaping Bunny Certified
Provisional Patent Filed
Dermatologist-Led Clinical Evaluation
Deployed in Clinics
Health Canada Notified
Leaping Bunny Certified
Provisional Patent Filed
Dermatologist-Led Clinical Evaluation

Ready to experience the difference? Join the early access list.

We work with dermatologists and clinic partners worldwide. Join the waitlist — or reach out to start a conversation.

BioThera Solutions

Scalable EV biomanufacturing — from dermocosmetics to regenerative medicine. Extracellular vesicles (EVs/exosomes) are the future of modern medicine, and we are pioneering that future from the ground up.

Ottawa, Ontario, Canada

© 2026 BioThera Solutions Inc. All rights reserved.

For informational purposes only. mPDEV is a cosmetic product and is not intended to diagnose, treat, cure, or prevent any disease.